Gene · 554
Papers2,697
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,697
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Preclinical long-term safety of intraspinal transplantation of human dorsal spinal GABA neural progenitor cells. | iScience | 2023 | 38026209 | PubTator, text mining | PubMed |
| Lack of racial and ethnic diversity in lung cancer cell lines contributes to lung cancer health disparities. | Front Oncol | 2023 | 38023251 | PubTator, text mining | PubMed |
| Vasopressin Analog [V4Q5]dDAVP Exerts Cooperative Anticancer Effects in Combination With Low-Dose 5-Fluorouracil on Aggressive Colorectal Cancer Models. | World J Oncol | 2023 | 38022396 | PubTator, text mining | PubMed |
| HA-Coated PLGA Nanoparticles Loaded with Apigenin for Colon Cancer with High Expression of CD44. | Molecules | 2023 | 38005286 | PubTator, text mining | PubMed |
| A Critical Analysis of the FDA's Omics-Driven Pharmacodynamic Biomarkers to Establish Biosimilarity. | Pharmaceuticals (Basel) | 2023 | 38004421 | PubTator, text mining | PubMed |
| The FDA's New Guideline "Generally Accepted Scientific Knowledge" (GASK): An Opportunity to Expedite the Approval of Biosimilars. | Pharmaceuticals (Basel) | 2023 | 38004383 | PubTator, text mining | PubMed |
| Comparing Effects of Tolvaptan and Instruction to Increase Water Consumption in ADPKD: Post Hoc Analysis of TEMPO 3:4. | Kidney360 | 2023 | 37986188 | PubTator, text mining | PubMed |
| Cryo-EM of Aβ fibrils from mouse models find tg-APPArcSwe fibrils resemble those found in patients with sporadic Alzheimer's disease. | Nat Neurosci | 2023 | 37973869 | PubTator, text mining | PubMed |
| [Reset osmostat syndrome - when hyponatremia become «a normal»: diagnostics, case report]. | Probl Endokrinol (Mosk) | 2023 | 37968953 | PubTator, text mining | PubMed |
| Effects of recombinant human brain natriuretic peptide combined with tolvaptan on cardiac and renal function and serum inflammatory factors in patients with severe heart failure. | Medicine (Baltimore) | 2023 | 37960770 | PubTator, text mining | PubMed |
| Structural basis for ligand recognition and signaling of hydroxy-carboxylic acid receptor 2. | Nat Commun | 2023 | 37932263 | PubTator, text mining | PubMed |
| Exploring the diversity of AVPR2 in Primates and its evolutionary implications. | Genet Mol Biol | 2023 | 37930141 | PubTator, text mining | PubMed |
| In silico pharmacological study of AQP2 inhibition by steroids contextualized to Ménière's disease treatments. | Front Neurol | 2023 | 37928160 | PubTator, text mining | PubMed |
| Copeptin in autosomal dominant polycystic kidney disease: real-world experiences from a large prospective cohort study. | Clin Kidney J | 2023 | 37915893 | PubTator, text mining | PubMed |
| The MHC Associated Peptide Proteomics assay is a useful tool for the non-clinical assessment of immunogenicity. | Front Immunol | 2023 | 37915568 | PubTator, text mining | PubMed |
| Three Pediatric Patients with Congenital Nephrogenic Diabetes Insipidus due to AVPR2 Nonsense Mutations and Different Clinical Manifestations: A Case Report. | Case Rep Nephrol Dial | 2023 | 37900924 | PubTator, text mining | PubMed |
| Novel Approaches in Chronic Renal Failure without Renal Replacement Therapy: A Review. | Biomedicines | 2023 | 37893201 | PubTator, text mining | PubMed |
| Unraveling the Complexity of Childhood Polycystic Kidney Disease: A Case Study of Three Sisters. | Children (Basel) | 2023 | 37892363 | PubTator, text mining | PubMed |
| Conjugated Nanoparticles for Solid Tumor Theranostics: Unraveling the Interplay of Known and Unknown Factors. | ACS Omega | 2023 | 37867666 | PubTator, text mining | PubMed |
| Simultaneous Echinococcal superinfection in a patient with polycystic liver disease. | Clin Case Rep | 2023 | 37867541 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554/papers?page=11